EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis

Pedram Keshoofi, Philipp Schindler, Florian Rennebaum, Friederike Cordes, Haluk Morgul, Moritz Wildgruber, Hauke S Heinzow, Andreas Pascher, Hartmut H Schmidt, Anna Hüsing-Kabar, Michael Praktiknjo, Jonel Trebicka und 1 weitere

BMC Gastroenterology · 25.04.2024 · 24 (1)

DOI: 10.1186/s12876-024-03232-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Gastroenterology, online erschienen am 25.04.2024. Verfasst von Pedram Keshoofi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic B, Department of Gastroenterology, Hepatology, Endocrinology, Infectiology, University Hospital Muenster, Albert-Schweitzer-Campus 1, …. Hauptthemen laut MEDLINE: Sarcopenia, Cholangitis, Sclerosing, Liver Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Münster.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Imaging-based assessment of sarcopenia is a well-validated prognostic tool for patients with chronic liver disease. However, little is known about its value in patients with primary sclerosing cholangitis (PSC). This cross-sectional study aimed to investigate the predictive value of the cross-sectional imaging-based skeletal muscle index (SMI) for transplant-free survival (TFS) in patients with PSC.

Methods

A total of 95 patients with PSC who underwent abdominal cross-sectional imaging between 2008 and 2022 were included in this retrospective study. SMI was measured at the third lumbar vertebra level (L3-SMI). The cut-off values to define sarcopenia were < 50 cm²/m² in male patients and < 39 cm²/m² in female patients. The primary outcome of this study was TFS, which was defined as survival without liver transplantation or death from any cause.

Results

Our study indicates that L3-SMI sarcopenia impairs TFS in patients with PSC (5-year TFS: 33.9% vs. 83.3%, p = 0.001, log-rank test). L3-SMI sarcopenia was independently associated with reduced TFS via multivariate Cox regression analysis (HR = 2.749; p = 0.028). Body mass index reduction > 10% at 12 months, which is used as MELD standard exception (SE) criterion in Eurotransplant (in Germany only until September 2023), was not significantly associated with TFS in the multivariate Cox regression analysis (HR = 1.417; p = 0.330). Substitution of BMI reduction with L3-SMI in the German SE criteria improved the predictive accuracy of TFS compared to the established SE criteria (multivariable Cox regression analysis: HR = 4.007, p < 0.001 vs. HR = 1.691, p = 0.141).

Conclusion

Imaging-based diagnosis of sarcopenia via L3-SMI is associated with a low TFS in patients with PSC and may provide additional benefits as a prognostic factor in patient selection for liver transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaCholangitis, SclerosingLiver TransplantationHumansMaleFemaleRetrospective StudiesCross-Sectional StudiesAdultMiddle AgedMuscle, SkeletalPrognosisPredictive Value of TestsTomography, X-Ray ComputedLumbar VertebraeBody Mass Index

Stichwörter der Autor:innen

Body mass indexChronic liver diseaseCirrhosis, meldSkeletal muscle indexStandard exception criteria

Autor:innen und Institutionen

  • Medical Clinic B, Department of Gastroenterology, Hepatology, Endocrinology, Infectiology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Bldg. A14, 48149, Muenster, Germany. p_kesh02@uni-muenster.de.
  • Clinic for Radiology, University Hospital Muenster, 48149, Muenster, Germany.
  • Medical Clinic B, Department of Gastroenterology, Hepatology, Endocrinology, Infectiology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Bldg. A14, 48149, Muenster, Germany.
  • Medical Clinic II, Euregio Hospital Nordhorn, 48529, Nordhorn, Germany.
  • Department for General, Visceral and Transplant Surgery, University Hospital Muenster, 48149, Muenster, Germany.
  • Department of Radiology, University Hospital LMU Munich, 81377, Munich, Germany.

Förderung

  • Universitätsklinikum Münster

Zitieren

APA

Keshoofi, P., Schindler, P., Rennebaum, F., Cordes, F., Morgul, H., Wildgruber, M., Heinzow, H. S., Pascher, A., Schmidt, H. H., Hüsing-Kabar, A., Praktiknjo, M., Trebicka, J., & Seifert, L. L. (2024). Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis. BMC Gastroenterology, 24(1). https://doi.org/10.1186/s12876-024-03232-9

Vancouver

Keshoofi P, Schindler P, Rennebaum F, Cordes F, Morgul H, Wildgruber M, et al. Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis. BMC Gastroenterology. 2024;24(1). doi:10.1186/s12876-024-03232-9

BibTeX
@article{Keshoofi2024,
  author = {Keshoofi, Pedram and Schindler, Philipp and Rennebaum, Florian and Cordes, Friederike and Morgul, Haluk and Wildgruber, Moritz and Heinzow, Hauke S and Pascher, Andreas and Schmidt, Hartmut H and Hüsing-Kabar, Anna and Praktiknjo, Michael and Trebicka, Jonel and Seifert, Leon Louis},
  title = {Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis},
  journal = {BMC Gastroenterology},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12876-024-03232-9}
}
Kostenlos starten →